Parse Biosciences Raises $41.5M Series B Round to Scale Single-Cell Sequencing Products and Expand Product Portfolio
Company to commercialize and create single-cell multi-omics products SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a company dedicated to…